SCHEMBL2564396

SCHEMBL2564396

NCc1ccc(-c2ccccc2O)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
HPGD P15428 1/20 0.58
BCL2L1 Q07817 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TAAR1 Q96RJ0 2/20 0.56
HRH3 Q9Y5N1 1/20 0.52
BACE1 P56817 2/20 0.49
KDM1A O60341 1/20 0.49
ABAT P80404 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.46
ESR2 Q92731 1/20 0.44
ADRB2 P07550 1/20 0.44
MAOB P27338 2/20 0.43
CSNK2A1 P68400 2/20 0.43
LTA4H P09960 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
DPP4 P27487 1/20 0.42
ENPP2 Q13822 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL27605724 0.98 ALDH1A1 (0.56) ALDH1A1HPGDBCL2L1HSD17B10TAAR1
SCHEMBL29157606 0.98 TAAR1 (0.59) ALDH1A1HPGDBCL2L1HSD17B10TAAR1
SCHEMBL28241229 0.92 TAAR1 (0.52) ALDH1A1HPGDBCL2L1HSD17B10TAAR1
SCHEMBL28089504 0.84 TAAR1 (0.68) TAAR1HRH3ABATLOXL2ADRB2
SCHEMBL28241230 0.83 TAAR1 (0.57) ALDH1A1HPGDBCL2L1HSD17B10TAAR1
SCHEMBL28241228 0.83 ABAT (0.67) ALDH1A1BCL2L1TAAR1HRH3BACE1
SCHEMBL2450409 0.82 ALDH1A1 (0.52) ALDH1A1HPGDBCL2L1HSD17B10TAAR1
SCHEMBL714236 0.82 ALDH1A1 (0.83) ALDH1A1HPGDBCL2L1HSD17B10BACE1
SCHEMBL29443997 0.82 ALDH1A1 (0.83) ALDH1A1HPGDBCL2L1HSD17B10BACE1
SCHEMBL5362598 0.80 TAAR1 (0.77) ALDH1A1HSD17B10TAAR1HRH3BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659016-A Cyclin modulators 嘉兴优博生物技术有限公司 2024-03-08 CN disclosed
WO-2024041661-A1 CYCLIN MODULATOR 嘉兴优博生物技术有限公司 2024-02-29 WO disclosed
EP-1813623-B1 PURINENUCLEOSIDE DERIVATIVE MODIFIED IN 8-POSITION AND MEDICINAL USE THEREOF KISSEI PHARMACEUTICAL (JP) 2011-11-09 EP disclosed
US-20100249054-A9 PURINE NUCLEOSIDE DERIVATIVE MODIFIED IN 8-POSITION AND MEDICAL USE THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2010-09-30 US disclosed
US-7795236-B2 Purine nucleoside derivative modified in 8-position and medical use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2010-09-14 US disclosed
US-20070179115-A1 Purinenucleoside derivative modified in 8-position and medical use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1813623-A1 PURINENUCLEOSIDE DERIVATIVE MODIFIED IN 8-POSITION AND MEDICINAL USE THEREOF Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249054-A9 PURINE NUCLEOSIDE DERIVATIVE MODIFIED IN 8-POSITION AND MEDICAL USE THEREOF NUDT1, PNP, SLC28A2 ALDH1A1 1093/4885HPGD 1335/4885BCL2L1 2889/4885
US-20070179115-A1 Purinenucleoside derivative modified in 8-position and medical use thereof NUDT1, SLC28A2, PNP ALDH1A1 1206/4885HPGD 1104/4885BCL2L1 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.